The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT02767401

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02767401
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02767401. Non-randomized; no masking; primary purpose treatment. Start 2015-09-15 (actual); primary completion 2018-08-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)
Condition
Hibernation, Myocardial
Condition
Complete Occlusion of Coronary Artery
Intervention (Device)
stenting or balloon expansion
Intervention (Drug)
aspirin, clopidogrel, ticagrelor, atorvastatin, rosuvastatin, betaloc
Lead sponsor
The First Affiliated Hospital of Dalian Medical University (class: other)
Collaborator
Beijing Anzhen Hospital (class: other)
Collaborator
First Hospital of China Medical University (class: other)
Collaborator
Nanfang Hospital, Southern Medical University (class: other)

Record details

Record id
cardio:ct-nct02767401
Content hash
75322e065e50532969a8d8d857d0ac3eec26edfc46a8eeccfa4e6244f9a20cc7